A rare ganglioneuroblastoma secreting dopamine and the value of its measurement in diagnosis and prognosis

Annals of Clinical Biochemistry

Volumn 43, Issue 1, 2006, Pages 73-76

  Sargazi, M ^a   Smith, M L ^a   Worth, R C ^b   Roberts, N B ^a  

^a ROYAL LIVERPOOL UNIVERSITY HOSPITAL   (United Kingdom)

^b Countess of Chester Hospital ^*  (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

(3 IODOBENZYL)GUANIDINE I 131; ADRENALIN; CATECHOLAMINE; DOPAMINE; METHYL GROUP; NORADRENALIN; TUMOR MARKER;

ADRENAL GLAND; ADULT; ARTICLE; BLOOD PRESSURE; CASE REPORT; COMPUTER ASSISTED TOMOGRAPHY; DIAGNOSTIC ERROR; DIAGNOSTIC VALUE; DOPAMINE RELEASE; DRUG MEGADOSE; FEMALE; FLUSHING; HUMAN; MEASUREMENT; NECK; NEUROBLASTOMA; PRIORITY JOURNAL; PROGNOSIS; RARE DISEASE; REFERENCE VALUE; SCREENING; TUMOR RECURRENCE; URINARY EXCRETION; URINE VOLUME;

DOPAMINE; FEMALE; GANGLIONEUROBLASTOMA; HUMANS; MIDDLE AGED; PROGNOSIS;

EID: 30844440301     PISSN: 00045632     EISSN: 00045632     Source Type: Journal    
DOI: 10.1258/000456306775141704     Document Type: Article

References (20)

1. Lonergan GJ, Col LT, Usaf MC, Cornelia M, Schwab MD, Suarez ES. Neuroblastoma, Ganglioneuroblastoma, and Ganglioneuroma. Radiol-Pathol Correl Rad 2002; 22: 911-934
2. Smircic L, Suscovic T, Ferencic Z. Phaeochromocytoma without hypertension. J Intern Med 1994; 235: 373-4
3. Riley RD, Heney D, Jones DR, et al. A systematic review of molecular and biological tumour markers in neuroblastoma. Clin Can Res 2004; 10: 4-12
4. Koike K, Iihara M, Kanbe M, Omi Y, Aiba M, Obara T. Adult-type ganglioneuroblastoma in the adrenal gland treated by a laparoscopic resection: report of a case. Surg Today 2003; 33: 2565-8
5. Tischler AS. Divergent differentiation in neuroendocrine tumours of the adrenal gland. Semin Diagn Pathol 2000; 17: 120-6
6. Kuwamura M, Kotera T, Yamate J, Kotani T, Aoki M, Hori A. Cerebral ganglioneuroblastoma in a golden retriever dog. Vet Pathol 2004; 41: 282-4
7. TamV, Ng KF, Fung LM, et al. The importance of the interpretation of urine catecholamines is essential for the diagnosis and management of patient with dopamine-secreting paraganglioma. Ann Clin Biochem 2005; 42: 73-7
8. Davidson DF. Phaeochrocytoma with normal urinary catecholamines: the potential value of urinary free metadrenalines. Ann Clin Biochem 2002; 39: 557-66
9. Hsiao CC, Huang CC, Sheen JM, et al. Differential expression of delta-like gene and protein in neuroblastoma, ganglioneuroblastoma and ganglioneuroma. Mod Pathol 2005; 18: 656-62
10. Hopfner M, Sutter AP, Beck NI, et al. Meta-Iodobenzylguanidine induces growth inhibition and apoptosis of neuroendocrine gastrointestinal tumour cells. Int J Cancer 2002; 101: 210-6
11. Miceli A, Nespoli L, Burgio GR, Aprile C, Carena M, Saponaro R. The role of meta-iodo benzylguanidine (MIBG) in the diagnosis and follow-up of neuroblastoma. Pediatr Hematol Oncol 1986; 3: 37-47
12. Schilling FH, Bihl H, Jacobsson H, et al. Combined (111)Inpentetreotide scintigraphy and (123)I-mIBG scintigraphy in neuroblastoma provides prognostic information. Med Pediatr Oncol 2000; 35: 688-91
13. Boyd M, Mairs R. Targeted therapy. Beatson Laboratories Scientific Report 2003 (www.beatson.gla.ac.uk/boyd_mairs.htm)
14. Davidson DF. Elevated urinary dopamine in adults and children. Ann Clin Biochem 2005; 42: 200-7
15. Peaston RT, Weinkove C. Measurement of catecholamines and their metabolites. Ann Clin Biochem 2004; 41: 17-38
16. Reeves C, Roberts NB, Fairclough D, Higgins G, Reed P. The comparison of urinary free and total methylated catecholamines with free catecholamines in the laboratory assessment of catecholamine secreting tumours. Proceedings of the ACB National Meeting, vol. 51, Birmingham, UK, 2004
17. Lenders JW, Pacak K, Walther MM, et al. Biochemical diagnosis of phaeochromocytoma: which test is best. JAMA 2002; 287: 1427-34
18. Eisenhofer G, Goldstein DS Walter MM, et al. Malignant phaeochromocytoma: how to distinguish true from false-positive test results. J Clin Endocrinol 2003; 88: 2656-66
19. Dubois LA, Gray DK. Dopamine-secreting pheochromocytomas: in search of a syndrome. World J Surg 2005; 29: 909-13
20. Eisenhofer G, Goldstein DS, Sullivan P, et al. Biochemical and clinical manifestations of dopamine - producing paragangliomas: utility of plasma methoxytyramine. J Clin Endo Metab 2005; 90: 2068-75